Does DENOSUMAB Cause Lung neoplasm malignant? 251 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 251 reports of Lung neoplasm malignant have been filed in association with DENOSUMAB (Bilprevda). This represents 0.2% of all adverse event reports for DENOSUMAB.
251
Reports of Lung neoplasm malignant with DENOSUMAB
0.2%
of all DENOSUMAB reports
74
Deaths
52
Hospitalizations
How Dangerous Is Lung neoplasm malignant From DENOSUMAB?
Of the 251 reports, 74 (29.5%) resulted in death, 52 (20.7%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 251 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which DENOSUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE